There is also contrast therapy that is vividly used in physiotherapy, especially sports physiotherapy, where a cold bath is ...
Though long COVID, or post-acute sequelae of SARS-CoV-2 (PASC), is more common in adults than in kids, 1.3% of US children ...
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to local medical professionals. "I think it could be a potentially ...
Yoga can help relieve sciatica pain and even prevent it from returning, as it helps improve spinal alignment and release tension. Here are the poses that help the most.
Contrary to prior data, this study shows that neither eosinophils nor STAT6-mediated IL-4/IL-13 signaling contribute ...
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback